A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia

NCT02952092 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemodialysis Chronic Kidney Disease Patients With Anemia

Interventions

DRUG: roxadustat
DRUG: Darbepoetin alfa

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]